Fig. 3From: Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients—a randomized clinical trialOverall survival: Kaplan-Meier curves by treatment group (intent-to-treat population). Arrows depict vaccination time points. Numbers reflect a number of subjects at risk. + Symbols denote censored patientsBack to article page